A Unique Collaboration
This unique collaborative team brings together all the capabilities needed to address the COVID-19 pandemic – computational expertise, clinical experience, advanced laboratory proficiency, and a deep knowledge of human and coronavirus genetics.
COV-IRT Project Goals:
Enhance public datasets to reveal host infection dynamics for SARS-CoV-2 to improve medical treatment options for COVID-19 patients.
Determine and design optimal targets for therapeutics against SARS-CoV-2
Creating new drug delivery systems based on targets
Test newly developed therapeutics in both in vitro and in vivo SARS-CoV-2 models
Apply for human clinical trials
COV-IRT was founded by Dr. Afshin Beheshti, Dr. Todd Treangen, and Dr. Krista Ternus and is led by Drs. Beheshti and Treangen. Members include scientists and experts from across the world, directors from both academic institutions and hospitals, senior and junior faculty, leaders from industry, graduate students, and postdocs.
Dr. Afshin Beheshti
Principal Investigator and Bioinformatician at NASA Ames Research Center/KBR, Adjunct Assistant Professor at Rutgers, and Visiting Researcher at Broad Institute
Dr. Todd Treangen
Assistant Professor in the Department of Computer Science, Rice University
Dr. Krista Ternus
Genomics Specialist in Biological Sciences, Signature Science, LLC
The Latest from the Newsroom
The COVID-19 International Research Team is already producing interesting analyses that can potentially bring mechanistic understanding of SARS-CoV-2 and help identify therapies. Visit the Newsroom for media coverage, research updates, upcoming events, and resources.